Biotech News
-
DIAGNOS to File for FDA Pre-Market Authorization of Its AI-Powered CARA SYSTEM and Engages Ora as Regulatory Specialist
February 25, 2025 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A),…
-
DIAGNOS to Present at Centurion One Capital 8th Annual Toronto Growth Conference
February 24, 2025 (Source) — Diagnos Inc. (TSXV: ADK) (OTCQB: DGNOF) (FSE: 4D4A) (“DIAGNOS” or the “Corporation”), a pioneer…
-
Voyageur Pharmaceuticals Grants Deferred Share Units
February 24, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC: VYYRF) (“Voyageur” or the “Corporation”), a provider of innovative…
-
Voyageur Advances MRI Drug Development Using Next Generation Endohedral Fullerenes
February 18, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“Voyageur” or the “Company”) is pleased to…
-
Voyageur Receives $600K Grant from Alberta Innovates for Product Development
Voyageur receives $600,000 in funding through Alberta Innovates AICE-Market Access Program February 5, 2025 (Source) — Voyageur Pharmaceuticals…
-
DIAGNOS Announces Closing of Private Placement
February 5, 2025 (Source) — DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer…
-
DIAGNOS Announces Financial Contribution of $400,000 from the Government of Canada
January 30, 2025 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A),…
-
DIAGNOS to Present at The Microcap Conference 2025
January 28, 2025 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A),…
-
Voyageur Secures $687k of Additional Capital from Warrant Exercises
Voyageur streamlines capitalization table through exercise of 5,725,829 warrants, expiry of 8,844,935 warrants Strong existing shareholder support, raising…
-
Voyageur Recaps Significant 2024 Achievements and Unveils Plans for Transformational 2025, Including Market Launch for Barium Suite of Products and Advancement of Iodine Suite
LOI with Multinational Contrast Media Company Voyageur Introduced Five New Health Canada Licensed Barium Contrast Products Securing 1st…
